Ramiro Ribeiro

CIK: 0002013623

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (36.8%)

Position reduction

Option Exercises (M)7 (36.8%)

Derivative conversions

Awards (A)4 (21.1%)

Compensation grants

Other (G, F, J, C, D, …)1 (5.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EYPT

EyePoint, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

EYPT
EyePoint, Inc.
Jun 30, 2026
Sale(S)
Direct
2.4K shares at avg. $15.02$37K
EYPT
EyePoint, Inc.
Jun 30, 2026
Exercise(M)
Direct
2.4K shares at avg. $8.26$20K
EYPT
EyePoint, Inc.
Jun 30, 2026
Exercise(M)
Direct
2.4K shares at avg. $8.26$20K
EYPT
EyePoint, Inc.
Jun 30, 2026
Sale(S)
Direct
2.4K shares at avg. $15.00$37K
EYPT
EyePoint, Inc.
Apr 17, 2026
Sale(S)
Direct
2.4K shares at avg. $15.00$37K
EYPT
EyePoint, Inc.
Apr 17, 2026
Exercise(M)
Direct
2.4K shares at avg. $8.26$20K
EYPT
EyePoint, Inc.
Mar 4, 2026
Exercise(M)
Direct
2.4K shares at avg. $8.26$20K
EYPT
EyePoint, Inc.
Mar 4, 2026
Sale(S)
Direct
2.4K shares at avg. $17.87$44K
EYPT
EyePoint, Inc.
Feb 17, 2026
Exercise(M)
Direct
2.4K shares at avg. $8.26$20K
EYPT
EyePoint, Inc.
Feb 17, 2026
Sale(S)
Direct
2.4K shares at avg. $15.00$37K
EYPT
EyePoint, Inc.
Jan 5, 2026
Sale(S)
Direct
42.5K shares at avg. $17.10$727K
EYPT
EyePoint, Inc.
Jan 5, 2026
Exercise(M)
Direct
29.3K shares at avg. $8.26$242K
EYPT
EyePoint, Inc.
Jan 3, 2026
Exercise(M)
Direct
19.7K shares-
EYPT
EyePoint, Inc.
Jan 3, 2026
Tax Payment(F)
Direct
6.4K shares at avg. $17.48$111K
EYPT
EyePoint, Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
171.4K shares-
EYPT
EyePoint, Inc.
Jan 2, 2026
Award(A)
Restricted Stock Units
Direct
85.7K shares-
EYPT
EyePoint Pharmaceuticals, Inc.
Nov 11, 2025
Sale(S)
Direct
2.7K shares at avg. $11.61$32K
EYPT
EyePoint Pharmaceuticals, Inc.
Jan 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
117K shares-
EYPT
EyePoint Pharmaceuticals, Inc.
Jan 3, 2025
Award(A)
Restricted Stock Units
Direct
59K shares-

		Type	Shares	Price		Ownership
Jun 30, 2026	EYPT EyePoint, Inc.	Sale(S)	2,438	$15.02	$36,612	Direct
Jun 30, 2026	EYPT EyePoint, Inc.	Exercise(M)	2,437	$8.26	$20,130	Direct
Jun 30, 2026	EYPT EyePoint, Inc.	Exercise(M)	2,438	$8.26	$20,138	Direct
Jun 30, 2026	EYPT EyePoint, Inc.	Sale(S)	2,437	$15.00	$36,555	Direct
Apr 17, 2026	EYPT EyePoint, Inc.	Sale(S)	2,437	$15.00	$36,555	Direct
Apr 17, 2026	EYPT EyePoint, Inc.	Exercise(M)	2,437	$8.26	$20,130	Direct
Mar 4, 2026	EYPT EyePoint, Inc.	Exercise(M)	2,438	$8.26	$20,138	Direct
Mar 4, 2026	EYPT EyePoint, Inc.	Sale(S)	2,438	$17.87	$43,572	Direct
Feb 17, 2026	EYPT EyePoint, Inc.	Exercise(M)	2,437	$8.26	$20,130	Direct
Feb 17, 2026	EYPT EyePoint, Inc.	Sale(S)	2,437	$15.00	$36,555	Direct
Jan 5, 2026	EYPT EyePoint, Inc.	Sale(S)	42,544	$17.10	$727,319	Direct
Jan 5, 2026	EYPT EyePoint, Inc.	Exercise(M)	29,250	$8.26	$241,605	Direct
Jan 3, 2026	EYPT EyePoint, Inc.	Exercise(M)	19,667	-	$0	Direct
Jan 3, 2026	EYPT EyePoint, Inc.	Tax Payment(F)	6,373	$17.48	$111,400	Direct
Jan 2, 2026	EYPT EyePoint, Inc.	Award(A) Stock Option (Right to Buy)	171,400	-	-	Direct
Jan 2, 2026	EYPT EyePoint, Inc.	Award(A) Restricted Stock Units	85,700	-	-	Direct
Nov 11, 2025	EYPT EyePoint Pharmaceuticals, Inc.	Sale(S)	2,722	$11.61	$31,602	Direct
Jan 3, 2025	EYPT EyePoint Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	117,000	-	-	Direct
Jan 3, 2025	EYPT EyePoint Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	59,000	-	-	Direct

1-19 of 19 transactions

About Ribeiro Ramiro

Ribeiro Ramiro (SEC CIK 0002013623) files insider reports with the SEC as Chief Medical Officer of EyePoint, Inc. (EYPT).

Signal8 holds 8 ownership filings by Ribeiro Ramiro, all Form 4s, filed between Jan 7, 2025 and Jul 2, 2026. Those filings report 19 transactions, from Jan 3, 2025 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ribeiro Ramiro's filings is in WATERTOWN, MA.

Recent filings by Ribeiro Ramiro

Jun 30, 2026: Open-market sale of EYPT shares (Form 4, code S).
Jun 30, 2026: Option exercises of EYPT shares (2 lines, Form 4, code M).
Jun 30, 2026: Open-market sale of EYPT shares (Form 4, code S).
Apr 17, 2026: Open-market sale of EYPT shares (Form 4, code S).
Apr 17, 2026: Option exercise of EYPT shares (Form 4, code M).

Other insiders filing for EyePoint, Inc. (EYPT)

Elston George, Chief Financial Officer
Zaderej Karen L., Director
Duker Jay S., President and CEO
Lurker Nancy, Director
Sanders Reginald J., Director
Landis John B., Director

How to read Form 4 transaction codes